Cilostazol attenuates cisplatin-induced acute liver injury by targeting the SIRT1/AMPK/PGC-1α signaling pathway, with an impact on miRNA-34a
Ahmed Amr Raouf, Aya H. El-Kadem, Samia S. Sokar, Mamdouh A. Oraby, Nagla A. El‐Shitany
Topics & Concepts
CilostazolAMPKPharmacologyMedicineCisplatinLiver injurymicroRNAChemistryInternal medicineProtein kinase AKinaseAspirinChemotherapyBiochemistryGeneSirtuins and Resveratrol in MedicineGenomics, phytochemicals, and oxidative stressChemotherapy-induced organ toxicity mitigation